Oglufanide
CAS No. 38101-59-6
Oglufanide( H-Glu-Trp-OH | L-Glutamyl-L-tryptophan )
Catalog No. M20677 CAS No. 38101-59-6
Oglufanide is a naturally occurring thymic immunomodulatorand inhibits vascular endothelial growth factor (VEGF).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 65 | In Stock |
|
| 10MG | 102 | In Stock |
|
| 25MG | 215 | In Stock |
|
| 50MG | 335 | In Stock |
|
| 100MG | 507 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOglufanide
-
NoteResearch use only, not for human use.
-
Brief DescriptionOglufanide is a naturally occurring thymic immunomodulatorand inhibits vascular endothelial growth factor (VEGF).
-
DescriptionOglufanide is a naturally occurring thymic immunomodulatorand inhibits vascular endothelial growth factor (VEGF).
-
In Vitro——
-
In VivoAnimal Model:C57BL/6 immune competent mice, Lewis lung carcinoma (LLC) xenograft; Balb/C athymic mice, M21 human melanoma xenograftDosage:1, 10, 50 and 100 mg/kg/day Administration:Subcutaneous injection, 10 days Result:Resulted in a dose-dependent inhibition of LLC tumor growth in syngeneic immune competent mice and showed a dose-dependent decrease in tumor volumes of xenografts in Balb/C athymic mice implanted with M21 human melanoma cells.
-
SynonymsH-Glu-Trp-OH | L-Glutamyl-L-tryptophan
-
PathwayAngiogenesis
-
TargetVEGFR
-
RecptorVEGFR
-
Research AreaInfection
-
IndicationColorectal Cancer; Hepatitis C; Influenza virus infections; Kaposi's sarcoma; Ovarian Cancer
Chemical Information
-
CAS Number38101-59-6
-
Formula Weight333.34
-
Molecular FormulaC16H19N3O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:15.5 mg/mL (46.50 mM)
-
SMILESN[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O
-
Chemical Name(S)-4-amino-5-(((S)-1-carboxy-2-(1H-indol-3-yl)ethyl)amino)-5-oxopentanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bayes M Rabasseda X Prous J R . Gateways to Clinical Trials[J]. Methods & Findings in Experimental & Clinical Pharmacology 2008 30(4):313.
molnova catalog
related products
-
8-O-Acetylshanzhisid...
8-O-Acetylshanzhiside methylester has potential against cerebral ischemic injury, and its protective effect on oxygen-glucose deprivation-induced injury might be due to the suppression of intracellular Ca2+ elevation and caspase-3 activity.
-
Asimadoline hydrochl...
Asimadoline HCl is a κ-opioid receptor agonist potentially for the treatment of pruritus. Asimadoline has also been shown to be used in the treatment of irritable bowel syndrome.
-
Sulfatinib (b)
Sulfatinib (HMPL-012) is a potent, multi-targeted tyrosine kinase inhibitor of VEGFR-1/2/3, FGFR1, CSF1R with IC50 of 2/24/1 nM, 15 nM, 4 nM, respectively.
Cart
sales@molnova.com